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Introduction
Polyketides are structurally diverse natural products from
plants and microorganisms that exhibit a broad range of bio-
logical activities.[1–3] They are assembled through a process sim-
ilar to fatty acid biosynthesis, involving one or more rounds of
decarboxylative condensation of an (alkyl) malonyl thioester
extender unit with an acyl thioester starter unit. Several dis-
tinct classes of polyketide synthases exist ; they are differentiat-
ed by their architectures and catalytic mechanisms.[4]
The type I PKSs each consist of one or more multifunctional
proteins containing various catalytic domains that are used to
assemble their metabolic products. With the exception of PKSs
that utilise trans-acting acyl transferases,[5] a type I PKS general-
ly contains a minimum of three domains: a ketosynthase (KS),
an acyl transferase (AT) and an acyl carrier protein (ACP). Op-
tional ketoreductase (KR), dehydratase (DH) and enoyl reduc-
tase (ER) domains define the degree of b-carbon processing
after each round of chain elongation.[6] Type I PKSs can be di-
vided into two subgroups.
The first subgroup is termed “modular”; a typical representa-
tive consists of a series of modules, each of which contains
a set of distinct catalytic domains that are responsible for one
round of chain elongation and subsequent b-carbon modifica-
tion in the overall chain assembly process. The archetypal ex-
ample of such PKSs is 6-deoxyerythronolide B synthase (DEBS),
which is involved in the biosynthesis of the antibiotic erythro-
mycin in the actinobacterium Saccharopolyspora erythraea.[7]
The second subgroup is termed “iterative” and is exemplified
by 6-methylsalicylic acid synthase (MSAS), found in many
fungi.
Type II PKSs each consist of a series of monofunctional en-
zymes that are used iteratively in the assembly of polycyclic ar-
omatic metabolites (e.g. , actinorhodin and tetracycline) and
are mainly found in Actinobacteria.[8–9]
Comparative transcriptional profiling of a DbldM mutant of
Streptomyces venezuelae with its unmodified progenitor re-
vealed that the expression of a cryptic biosynthetic gene clus-
ter containing both type I and type III polyketide synthase
genes is activated in the mutant. The 29.5 kb gene cluster,
which was predicted to encode an unusual biaryl metabolite,
which we named venemycin, and potentially halogenated de-
rivatives, contains 16 genes including one—vemR—that enco-
des a transcriptional activator of the large ATP-binding LuxR-
like (LAL) family. Constitutive expression of vemR in the DbldM
mutant led to the production of sufficient venemycin for struc-
tural characterisation, confirming its unusual biaryl structure.
Co-expression of the venemycin biosynthetic gene cluster and
vemR in the heterologous host Streptomyces coelicolor also re-
sulted in venemycin production. Although the gene cluster
encodes two halogenases and a flavin reductase, constitutive
expression of all three genes led to the accumulation only of
a monohalogenated venemycin derivative, both in the native
producer and the heterologous host. A competition experi-
ment in which equimolar quantities of sodium chloride and
sodium bromide were fed to the venemycin-producing strains
resulted in the preferential incorporation of bromine, thus sug-
gesting that bromide is the preferred substrate for one or both
halogenases.
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Type III PKSs (e.g. , chalcone and stilbene synthases) were
first identified in plants, but have since been found in many
eubacteria.[10] They are multifunctional enzymes that catalyse
elongation of diverse acyl-CoA starter units with one or more
malonyl-CoA extender units to form poly-b-ketoacyl-CoA inter-
mediates that undergo a range of cyclisation reactions to form
diverse aromatic products.[4, 7, 11] This type of PKS is exemplified
by RppA, which assembles 1,3,6,8-tetrahydroxynaphthalene
(THN) in several Streptomyces species.[12–15]
Streptomyces is the largest genus within the Actinobacteria
phylum. Streptomyces species are a prolific source of antibiotics
and other bioactive natural products with a broad range of ap-
plications in both medicine and agriculture.[16] The recent se-
quencing of a large number of actinobacterial genomes has re-
vealed the presence of numerous gene clusters with the po-
tential to direct the biosynthesis of new specialised metabo-
lites. However, in most cases the metabolic products of such
cryptic gene clusters remain to be identified, presumably be-
cause they are not expressed under laboratory growth condi-
tions.[17] Although well known as a producer of chlorampheni-
col, Streptomyces venezuelae ATCC 10712 failed to produce this
antibiotic in our laboratory under a range of culture condi-
tions. However, for reasons that we do not yet understand, de-
letion of bldM, which encodes an atypical response regulator
required for morphological development,[18] activated tran-
scription of the chloramphenicol biosynthetic gene cluster.[19]
Here we report the discovery of an unusual biaryl polyketide
as the metabolic product of a cryptic polyketide biosynthetic
gene cluster that was identified by comparative transcriptional
analyses of the wild-type and DbldM strains of S. venezuelae.
Results and Discussion
Identification of a cryptic polyketide biosynthetic gene
cluster in S. venezuelae and prediction of its biosynthetic
product
Comparative microarray analysis of wild-type S. venezuelae and
a congenic bldM mutant (strain SV13)[18] revealed the presence
of a previously unidentified cryptic polyketide biosynthetic
gene cluster (vem), expression of which was markedly upregu-
lated in the mutant (Figure 1). The cluster is approximately
29.5 kb in size and contains 15 upregulated genes: sven0482,
sven0483, and sven0485–sven0497. The transcriptional profiles
of the flanking genes sven0477–sven0481 and sven0498–
sven0502, which were expressed at low levels both in the wild-
type strain and in the bldM mutant (data not shown), indicated
that they were unlikely to be functionally related to the vem
cluster (sven0482–sven0497). From the amino acid sequence
similarity of the encoded proteins to those present in the NCBI
protein database we predicted their putative functions
(Table 1) and proposed a biosynthetic pathway (Scheme 1)
that, if correct, would result in the production of a new biaryl
metabolite—which we named venemycin—and halogenated
derivatives.
We propose that the biosynthesis of venemycin begins with
the formation of 3,5-dihydroxybenzoic acid catalysed by the
enzymes encoded by vemA, vemB, vemC, vemD, vemE and
vemF. VemA–F are homologues of Ken2–7, which have been
proposed to catalyse the formation of the 3,5-dihydroxybenzo-
ic acid starter unit utilised by a type I modular PKS for the as-
sembly of kendomycin in Streptomyces violaceoruber.[20] VemA
has 60–70% identity to DpgA, a type III PKS that has been
shown to catalyse the conversion of four malonyl-CoA
Figure 1. Microarray expression profiles of sven0482–sven0497 in the S. venezuelae bldM mutant (left) in comparison with the wild-type strain (right) ; the pro-
files for sven0484 are indicated by red arrows. The y-axis represents normalised transcript abundance and the x-axis indicates the times, in hours, after which
cultures were harvested for analysis.
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molecules to (3,5-dihydroxyphenyl)acetyl-CoA.[21] VemB and
VemD are homologues of DpgB and DpgD, respectively, which
have been shown to increase the efficiency of the DpgA-cata-
lysed reaction.[21] VemC is a homologue of DpgC, a cofactor-in-
dependent dioxygenase that has been shown to catalyse the
conversion of (3,5-dihydroxyphenyl)acetyl-CoA to (3,5-dihy-
droxyphenyl)oxoacetic acid.[22] The (3,5-dihydroxyphenyl)glyox-
ylic acid produced by the DpgA–D enzymes, which are univer-
sally conserved in glycopeptide-producing Actinobacteria, is
converted into (3,5-dihydroxyphenyl)glycine, a nonproteinogen-
ic amino acid incorporated into antibiotics such as balhimy-
cin,[23] vancomycin,[21] teicoplanin[24] and A47934.[25,26] It is pro-
posed that VemE catalyses the thiamine-diphosphate (TDP)-de-
pendent decarboxylation of (3,5-dihydroxyphenyl)oxoacetic
acid to form 3,5-dihydroxybenzaldehyde, which is oxidised to
3,5-dihydroxybenzoic acid by VemF, a putative nicotinamide-
dependent dehydrogenase.
We suggest that 3,5-dihydroxybenzoic acid serves as a starter
unit for the assembly of venemycin by the type I modular PKSs
VemG and VemH. Conserved domain searches revealed that
VemG contains at its N terminus a loading module consisting
of an adenylation (A) domain, a ketoreductase (KR) domain
(predicted to be nonfunctional because it lacks a canonical
YXXXN motif at its active site, even though it appears to con-
tain an NADPH binding site) and an ACP domain. The A do-
main has 63% amino acid sequence similarity to the corre-
sponding domain at the N terminus of the type I modular PKS
responsible for the assembly of kendomycin, which has been
proposed to load a 3,5-dihydroxybenzoic acid starter unit onto
the PKS.[20] At its C terminus, VemG has a chain elongation
module that contains KS, AT and ACP domains. VemH is pre-
dicted to contain a second chain elongation module consisting
of KS, AT and ACP domains, followed by a thioesterase (TE)
domain. The AT domains in VemG and VemH are both predict-
Table 1. Proposed functions of genes within the venemycin biosynthetic gene cluster.
Gene, sven number
(number of encoded
aas)
Proposed function Closest homologue with known/predicted func-
tion (in NCBI database 27/06/16)
Identity [%]
(identity/length
of alignment)
vemA, sven0493 (361) (3,5-dihydroxyphenyl)acetyl-CoA biosynthesis CAQ52620; type III PKS [S. violaceoruber] 71 (253/356)
CAE53371; DpgA protein [Actinoplanes teichomy-
ceticus]
67 (233/346)
vemB, sven0494 (236) (3,5-dihydroxyphenyl)acetyl-CoA biosynthesis CAC48379; DpgB, enoyl-CoA hydratase [Amyco-
latopsis balhimycina DSM 5908]
50 (106/211)
vemC, sven0495 (462) conversion of (3,5-dihydroxyphenyl)acetyl-CoA into (3,5-
dihydroxyphenyl)glyoxylic acid
AHF20612; dioxygenase [Amycolatopsis sp.
MJM2582]
61 (263/434)
CAQ52618; dioxygenase [S. violaceoruber] 56 (250/447)
vemD, sven0483 (267) (3,5-dihydroxyphenyl)acetyl-CoA biosynthesis WP_023546756; enoyl-CoA hydratase [Strepto-
myces roseochromogenus]
85 (228/267)
CAE53374; DpgD, enoyl-CoA hydratase [A. tei-
chomyceticus]
67 (175/206)
vemE, sven0496 (577) TDP-dependent decarboxylase responsible for conversion of
(3,5-dihydroxyphenyl)glyoxylic acid into 3,5-dihydroxy-
benzaldehyde
WP_023546769; thiamine-pyrophosphate-bind-
ing protein [Streptomyces roseochromogenes]
86 (497/575)
CAQ52617; benzoylformate decarboxylase [S. vi-
olaceoruber]
65 (378/580)
vemF, sven0497 (486) aldehyde dehydrogenase responsible for conversion of 3,5-
dihydroxybenzaldehyde into 3,5-dihydroxybenzoic acid
WP_023546770; benzaldehyde dehydrogenase
[S. roseochromogenus]
87 (419/483)
CAQ52616; benzaldehyde dehydrogenase [S. vio-
laceoruber]
67 (322/480)
vemG, sven0486 (2236) type I modular PKS WP_053663290; type I polyketide synthase
[Streptomyces sp. NRRL F-7442]
72 (1646/2289)
vemH, sven0485 (1325) type I modular PKS WP_023546758; type I polyketide synthase
[S. roseochromogenus]
80 (1069/1333)
AEZ54379; PieA6, polyketide synthase [Strepto-
myces piomogenus]
52 (699/1338)
vemI, sven0484 (231) 4-phosphopantetheinyl transferase WP_051820474; 4-phosphopantetheinyl transfer-
ase [Streptomyces flavochromogenes]
72 (165/228)
vemJ, sven0487 (425) FADH2-dependent halogenase EST32607; tryptophan halogenase [S. roseochro-
mogenus ssp. oscitans DS 12.976]
94 (400/425)
vemK, sven0488 (561) FADH2-dependent halogenase WP_023546761; FAD-dependent oxidoreductase
[S. roseochromogenus]
93 (521/559)
vemL, sven0489 (175) flavin reductase WP_023546762; oxidase [S. roseochromogenus] 86 (151/175)
sven0490 (216) isochorismatase WP_030556570; isochorismatase [Streptomyces
exfoliatus]
52 (115/222)
vemN, sven0482 (451) MPS transporter WP_055468166; MPS transporter [Streptomyces
sp. NBRC 110030]
76 (343/451)
vemO, sven0491 (520) transporter WP_050486995; MFS transporter [Streptomyces
sp. CNS654]
87 (439/503)
vemR, sven0492 (949) LAL pathway-specific activator GAT71280; ATPase [Planomonospora sphaerica] 39 (372/946)
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ed to be specific for malonyl-CoA.[27] The TE domain likely cat-
alyses release of the fully assembled polyketide chain to form
the pyrone, although hydrolytic release to form a somewhat
less stable 3,5-diketo acid would also be possible. VemI is
a phosphopantetheinyl transferase (PPTase) that is proposed to
be responsible for posttranslational phosphopantetheinylation
of the three ACP domains within the modular PKS; surprisingly,
because it is embedded in the cluster, transcription of vemI
(sven0484) was not markedly increased in the bldM mutant
(Figure 1), and it is conceivable that under the growth condi-
tions used this function is mainly performed by one of the
other PPTases encoded in the S. venezuelae genome by
sven0914, sven6190, sven6269 and sven4419 (the last of these is
likely to be the PPTase used in fatty acid synthesis). Either of
the aromatic rings of venemycin could then be halogenated
by one or both of the two putative flavin-dependent halogen-
ases, VemJ and VemK, with the FADH2 cofactor required by
these enzymes being supplied by the flavin reductase VemL.
VemN and VemO belong to the major facilitator superfamily
(MFS) transporters and are presumably involved in the export
of venemycin. VemR is a member of the large ATP-binding
LuxR-like (LAL) family of transcriptional regulators and is pro-
posed to function as a pathway-specific activator of the bio-
synthetic gene cluster. The protein contains a N-terminal AAA-
ATPase domain and a C-terminal LuxR family DNA-binding
domain with a helix-turn-helix motif. LAL homologues have
been shown to activate the production of several actinomy-
cete specialised metabolites, including pikromycin (PikD),[28] ra-
pamycin (RapH)[29] and the stambomycins (SAMR0484).[30]
Sven0490 is homologous to isochorismatases that convert iso-
chorismate into 2,3-dihydro-2,3-dihydroxybenzoate. These en-
zymes commonly participate in the biosynthesis of nonriboso-
mal peptide siderophores, and there is no apparent role for
Sven0490 in venemycin biosynthesis.
Identification of venemycin and a chlorinated derivative
Our proposed biosynthetic pathway (Scheme 1) predicted that
S. venezuelae should produce a potentially new metabolite
with the molecular formula C11H8O5, as well as halogenated de-
rivatives. On the basis of this prediction, we set out to identify
and characterise the products of the vem gene cluster by com-
parative metabolite profiling of culture supernatants from the
S. venezuelae DbldM mutant (strain SV13) and its parental
strain after growth for four days in liquid maltose-yeast ex-
tract-malt extract medium made with tap water (MYM-TAP)
and supplemented with trace elements. LC-HRMS identified
molecular ions corresponding to [M+H]+ for venemycin [m/z
calcd for C11H9O5
+ : 221.0444; found: 221.0443 (an absorbance
maximum at 324 nm was observed in the UV/visible spectrum
for this species; Figure S1 in the Supporting Information)] and
a monochlorinated derivative [m/z calcd for C11H8O5Cl
+ :
255.0055; found: 255.0051 (Figure S2)] that were present only
in the culture supernatant of the mutant strain. The com-
pounds were detectable at 48 h of growth and their levels
peaked between 72 and 96 h; after 120 h they had declined by
30% (data not shown).
Heterologous expression of the vem gene cluster in S. coeli-
color and structure elucidation of venemycin
Because the levels of production of venemycin and its mono-
chlorinated derivative by the S. venezuelae DbldM mutant were
insufficient to permit further structural analysis, and to confirm
Scheme 1. Organisation of the vem cluster in S. venezuelae and proposed pathway for the biosynthesis of venemycin. The presence of two genes (vemJ,
vemK) encoding FAD-dependent halogenases suggests that halogenated derivatives of venemycin might also be produced (the examples given are of chlori-
nated derivatives).
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that the vem gene cluster does indeed direct venemycin bio-
synthesis, we set out to express the gene cluster in a heterolo-
gous host. The cosmid derivative pIJ13035 (Table S1) contain-
ing the entire vem gene cluster was introduced into Streptomy-
ces coelicolor M1152[31] and M1316[32] (a derivative of M1152
from which two native type III PKS genes have been deleted;
Table S1) by conjugation from Escherichia coli. Chromosomal
integration was confirmed by PCR analysis, yielding S. coelicolor
M1818 and M1819, respectively. The strains were grown as de-
scribed above, and their culture supernatants were analysed
by LC-MS. Neither venemycin nor its chlorinated derivative was
detected (data not shown); this probably reflects a lack of tran-
scription of the vem gene cluster in the heterologous hosts.
To surmount this problem, vemR, encoding a putative tran-
scriptional activator of the LAL family, was cloned downstream
of the constitutive ermE* promoter within the integrative
pIJ10257 vector,[33] and the resulting plasmid pIJ13028 was in-
troduced into both S. coelicolor M1818 and M1819 by conjuga-
tion from E. coli, yielding S. coelicolor M1822 (M1152+vem
cluster+ermE*p::vemR) and S. coelicolor M1825 (M1316+vem
cluster+ermE*p::vemR), respectively. Chromosomal integration
of pIJ13028 in each of the recipient strains was confirmed by
PCR analysis (data not shown). Cultivation of both M1822 and
M1825 resulted in the production of a metabolite with the
same molecular formula, retention time and MS/MS fragmenta-
tion pattern as venemycin produced by S. venezuelae SV13
(Figure 2). Sometimes, but not always, a very small amount of
a singly chlorinated derivative of venemycin was also detected
in the culture supernatants of these strains (data not shown).
S. coelicolor derivatives containing pIJ13028 but lacking the
vem gene cluster did not produce venemycin or its chlorinated
derivative (data not shown). This confirmed that pIJ13035 con-
tains all of the genes required for venemycin biosynthesis. In-
troduction of pIJ13028 into wild-type S. venezuelae (yielding
M1815) also resulted in venemycin production (Figure 2), thus
providing further evidence that VemR is a transcriptional acti-
vator. Levels of production were further increased when the
same plasmid was introduced into the S. venezuelae DbldM
mutant (to give M1817), yielding sufficient venemycin for
structure elucidation by NMR spectroscopic analysis (Scheme 2
and Table S3). Venemycin was purified from M1817 by semipre-
parative HPLC and analysed by 1H and HSQC and HMBC NMR
experiments (Figures 3 and S3–S6). The NMR analyses estab-
lished that 3,5-dihydroxybenzoic acid had co-purified with ven-
emycin, consistent with its proposed role as an intermediate in
venemycin biosynthesis (Figures S3–S7). A search of the Sci-
Finder database established that although venemycin had not
been reported previously as a natural product it is a known
synthetic compound with potent superoxide anion radical
scavenging activities.[34]
Figure 2. Left : Extracted ion chromatograms at m/z 221.04:0.1 from positive-ion-mode UHPLC-ESI-TOF-MS analyses of culture supernatants from strains con-
taining pIJ13028 (ermE*p::vemR). M1815, S. venezuelae wild-type; M1817, S. venezuelae (DbldM) ; M1822, S. coelicolor M1152 containing the vem gene cluster ;
M1825, S. coelicolor M1316 containing the vem gene cluster. The strains were grown in MYM-TAP medium for four days before sampling. Right: Mass and UV/
Vis spectra for the analyte with a retention time of &12 min. Comparison of the measured mass spectrum with the simulated spectrum for C11H905+ estab-
lished the molecular formula of venemycin as C11H8O5.
Scheme 2. Structure of venemycin (left) and correlations observed in its
HMBC spectrum (right).
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Halogenation of venemycin
Because production levels of the monochlorinated derivative
of venemycin were low and no doubly halogenated venemycin
derivatives could be detected despite the presence of two
genes (vemJ and vemK) encoding putative FADH2-dependent
halogenases, we decided to express vemJ, vemK and vemL (en-
coding a flavin reductase) from the strong constitutive ermE*
promoter. The genes were cloned into the conjugative multi-
copy vector pIJ12477[35] (Table S1), and the resulting plasmid—
pIJ13029 (ermE*p::vemJKL)—was introduced into S. venezuelae
M1815 (wild-type+ermE*p::vemR) and M1817 (DbldM+
ermE*p::vemR), as well as S. coelicolor M1822 (M1152+vem
cluster+ermE*p::vemR) and M1825 (M1316+vem cluster+
ermE*p::vemR), yielding strains M1827, M1831, M1835 and
M1839, respectively. The strains were grown as before in liquid
MYM-TAP medium supplemented with trace elements, and the
culture supernatants were analysed by LC-HRMS in negative-
ion mode, which resulted in increased sensitivity relative to the
earlier analyses carried out in positive-ion mode. Venemycin
and its monochlorinated derivative were detected in all of the
cultures (data not shown), but the amounts produced were
still insufficient to permit further structural characterisation of
the chlorinated form, and no polyhalogenated venemycin de-
rivatives were detected. From HPLC profiles with UV- and visi-
ble-range detection, the levels of production of venemycin
and the monochlorinated form in S. coelicolor strains M1835
and M1839 were generally about half those observed in the
S. venezuelae DbldM derivative M1817 (data not shown). The
two heterologous hosts produced similar amounts.
Some flavin-dependent halogenases prefer bromide over
chloride,[36] but because chloride is the most abundant halide
in commonly used culture media, it is chlorine rather than bro-
mine that is usually incorporated into metabolic products
under laboratory conditions. To test whether bromide ions are
accepted or even preferred by VemJ/VemK, S. venezuelae
M1831 (DbldM+ermE*p::vemR+ermE*p::vemJKL) and S. coeli-
color M1835 (M1152+vem-cluster+ermE*p::vemR+
ermE*p::vemJKL) were cultivated in a minimal medium (MM)
supplemented with NaCl or NaBr. A monobrominated venemy-
cin derivative was readily detected in the culture supernatants
of both strains (Figure S8). Because heterologous expression in
S. coelicolor had worked well (Figures 3 and S8), we repeated
the experiment with M1822 and M1835 in modified R3
medium supplemented with NaCl, NaBr, or equimolar amounts
of both. A 13:1 ratio of monobrominated to monochlorinated
venemycin derivatives was observed in the culture containing
equimolar amounts of NaCl and NaBr, thus indicating that bro-
mide is the preferred substrate for one or both of the halogen-
ases encoded in the venemycin biosynthetic gene cluster
(Figure 3). Although the monobrominated venemycin deriva-
tive constituted almost 60% of the venemycin-related metabo-
lites produced in the culture containing NaBr, the amount pro-
duced was not sufficient to permit further structural analysis.
Halogenation of a natural product can significantly affect its
biological activity, including its antibacterial activity.[37–39] We
thus investigated the activity of culture supernatants of M1835
containing venemycin, and its monochlorinated and monobro-
minated derivatives, against Micrococcus luteus and E. coli, but
no growth inhibition was observed (data not shown).
Transcriptional organisation of the vem gene cluster
Inspection of the sequence of the vem gene cluster (Figure 1)
revealed the presence of multiple transcription units, and sev-
eral potential operons. To throw light on how expression of
the gene cluster might be regulated, and to provide a basis for
future attempts to increase the level of productivity—by engi-
neering enhanced levels of transcription, for example—the
operon structure of the vem gene cluster was determined.
RNA was isolated from mycelium of S. coelicolor M1825
(M1316+vem cluster+ermE*p::vemR) after two days of incu-
bation, corresponding to the onset of venemycin production,
and cDNA was synthesised by a two-step RT-PCR protocol with
random hexamers in the presence of reverse transcriptase (RT).
The resulting cDNA was used as a template for PCR amplifica-
tion with primers flanking 14 intergenic regions within the pro-
Figure 3. LC-MS analyses (negative-ion mode) of venemycin and halogen-
ated derivatives produced by S. coelicolor M1822 (M1152+vem gene clus-
ter+ermE*p::vemR) and S. coelicolor M1835 (M1822+ermE*p::vemJKL)
grown for seven days in R3 medium supplemented with NaCl alone, NaBr
alone or NaCl+NaBr. A) Extracted ion chromatograms for m/z 219.0299
(c), 252.9909 (c) and 296.9404 (c), corresponding to calculated
[M@H]@ m/z for venemycin and its monochlorinated and monobrominated
derivatives, respectively (y-axis, intensity units V106). B) Extracted UV/visible
chromatogram at 329 nm (maximum of absorbance under these conditions;
y-axis=mAU) for sample “M1835+Cl+Br”, illustrating the ratio of conver-
sion of venemycin to its singly chlorinated or brominated derivatives when
the three halogenation genes are constitutively expressed. C) MS spectra
(zoomed-in) of the peaks corresponding to each of the venemycin species
(y-axis, intensity unitsV106).
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posed vem gene cluster (Table S2). The fidelity of the primers
used was confirmed by using pIJ13035 DNA as template. Each
pair produced a single PCR product of the predicted size. The
results suggested the existence of eight transcription units:
vemN, vemD, vemI, vemGH, vemJK, vemL-sven0490-vemO, vemR
and vemABCEF (Figure 4). Attempts to use RT-PCR to amplify
cDNA derived from hrdB, encoding the housekeeping s factor
of S. coelicolor, by using RNA treated with and without reverse
transcriptase and 35 cycles of amplification confirmed the ab-
sence of genomic DNA.
Conclusion
By combining microarray analysis of a S. venezuelae DbldM
mutant with bioinformatics analysis of its genome sequence,
we were able to identify a biosynthetic gene cluster encoding
an unusual combination of modular type I and type III PKSs
that was predicted to assemble a new biaryl natural product—
which we named venemycin—along with halogenated deriva-
tives. Comparative analysis of the metabolites produced by the
wild-type strain and the DbldM mutant by using UHPLC-ESI-Q-
TOF-MS identified two compounds with molecular formulae
corresponding to venemycin and a monochlorinated deriva-
tive. However, the quantities of these metabolites were insuffi-
cient to permit structure elucidation by NMR spectroscopic
analysis. Thus, vemR, which encodes a putative LAL transcrip-
tional activator, was constitutively expressed in S. venezuelae
and in S. coelicolor derivatives containing the cloned vem gene
cluster. This provided sufficient quantities of venemycin for
NMR analysis, thus confirming that it has the structure predict-
ed by bioinformatics. Although the vem gene cluster contains
two halogenase genes (vemJ and vemK), we were only able to
detect the production of monohalogenated venemycin deriva-
tives. It is conceivable that one of the halogenases is not func-
tional, or that each of the halogenases modifies venemycin at
a different position and the monohalogenated venemycin de-
rivatives are not substrates for the remaining halogenase. In
a competitive feeding experiment employing equimolar con-
centrations of chloride and bromide, the monobrominated
venemycin derivative(s) was/were produced at a 13-fold higher
level than the monochlorinated derivative(s), thus indicating
that one or both of the halogenases has a significant prefer-
ence for the larger halide ion. Although venemycin is pro-
duced in part by a type III PKS, there were no significant differ-
ences in the levels of production in M1152 and M1316, a deriv-
ative of M1152 in which two type III PKS genes have been de-
leted and in which precursor supply for heterologously syn-
thesised venemycin might have been better. It remains to be
seen whether this is true for other metabolites derived from
malonyl-CoA. Our biosynthetic scheme has no role for
sven0490 (encoding a putative isochorismatase), and indeed,
deletion of this gene in S. coelicolor M1825 had no effect on
venemycin production (A. Thanapipatsiri, unpublished data).
This is particularly surprising because sven0490 is co-tran-
scribed with vemL and vemO.
Experimental Section
Bacterial strains, plasmids, cosmids and culture conditions : The
strains, plasmids and cosmids used in this study are listed in
Table S1. E. coli strains were grown and manipulated by standard
methods.[40–42] For generating spore stocks, S. venezuelae and
S. coelicolor were grown on MYM-TAP agar[43] and mannitol soya
flour (SFM) agar,[44] respectively. MYM-TAP liquid medium (with
400 mL of trace element solution[44] added per 200 mL of medium
added after autoclaving) was used to grow Streptomyces strains for
venemycin production and for RNA isolation from S. coelicolor
M1825. For the halogenation studies we used Minimal Medium
(MM)[44] supplemented with NaCl or NaBr (0.5 gL@1), and modified
Figure 4. RT-PCR was used to identify likely operons (! ) in the vem cluster. Translationally coupled genes are shaded in grey, and asterisks indicate occur-
rences of translational coupling. “c” and “cm” indicate amplification from cDNA and cosmid DNA, respectively. hrdB of S. coelicolor M145 was used as an inter-
nal control. hrdB (@ve) indicates attempted PCR amplification of hrdB from RNA extracted from S. coelicolor M1825 without cDNA synthesis. hrdB (+ve) indi-
cates PCR amplification of hrdB from S. coelicolor M145 genomic DNA. A 100 bp DNA ladder (NEB) was used as the DNA size marker.
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versions of R3 medium[45] consisting of glucose (10 gL@1), yeast ex-
tract (5 gL@1), casamino acids (100 mgL@1), proline (3 gL@1),
MgSO4·7H2O (10 gL
@1), CaSO4·2H2O (4 gL
@1), K2SO4 (200 mgL
@1),
KH2PO4 (50 mgL
@1), TES [N-tris(hydroxymethyl)methyl-2-aminoetha-
nesulfonic acid, 5.6 gL@1] , trace elements (as described for R2YE
medium[44]) and NaCl or NaBr or both (1 gL@1) ; the media were ad-
justed to pH 7.2 with NaOH and autoclaved. Streptomyces liquid
cultures were performed in medium (50 mL) in 250 mL flasks con-
taining stainless steel springs to promote dispersed growth with at
least two replicates. The cultures were grown at 30 8C with shaking
at 250 rpm for up to five days. Antibiotics were added to the
media at the following final concentrations when appropriate:
apramycin (50 mgmL@1), nalidixic acid (25 mgmL@1), kanamycin
(10 mgmL@1 for S. venezuelae and 50 mgmL@1 for S. coelicolor), and
hygromycin (25 mgmL@1 for S. venezuelae and 50 mgmL@1 for
S. coelicolor).
Microarray analysis : RNA isolation from S. venezuelae and subse-
quent DNA microarray analysis were reported previously,[46] and
the data were deposited in the arrayExpress database (https://
www.ebi.ac.uk/arrayexpress/) under accession number E-MTAB-
2716. Briefly, data in CEL files produced by the chip scanner were
normalised by using robust multi-array average (RMA) as imple-
mented in the Affy package of Bioconductor (https://www.biocon-
ductor.org/). Replicates were combined by using the lmFit and
eBayes functions of the limma package of Bioconductor. This re-
sulted in a table of log2 expression values for each gene at various
time points in the different strains. For the analysis reported here,
the log2 expression values for the relevant genes (sven0477–
sven0481, sven0482–sven0497 and sven0498–sven0502) in the bldM
mutant and the wild-type strains were extracted from the
genome-wide data set, centred to a mean of zero for each gene
(by using the scale function of R) and then plotted by using R
(https://www.R-project.org/).
DNA and RNA manipulations : DNA extraction from E. coli was car-
ried out by standard methods[42] or with a QIAprep Spin Miniprep
Kit (Qiagen). Restriction enzymes (Roche and NEB) were used ac-
cording to the instructions provided by the manufacturers. PCR
amplifications were performed with Taq DNA polymerase (Qiagen).
The amplification of DNA fragments used in the expression con-
structs was performed with Phusion High-Fidelity DNA Polymerase
(NEB). Extraction of RNA from Streptomyces strains was performed
with a RNeasy mini kit (Qiagen, Supporting Information). RT-PCR
was performed with a Maxima First Strand cDNA Synthesis kit
(Thermo Scientific). Amplification of DNA from synthesised cDNA
was carried out with Taq DNA polymerase (Qiagen).
Annotation of the vem cluster : The Streptomyces genome server
(StrepDB: http://strepdb.streptomyces.org.uk) was used to derive
the amino acid sequences for each of the proteins encoded by the
vem cluster. These were then used in BlastP searches of the NCBI
protein database to assign the probable function of each gene.
Generation of a transmissible cosmid for heterologous expres-
sion of the vem cluster in S. coelicolor : PCR targeting[41] of cosmid
SV3E02, which contains the vem cluster, was carried out to replace
neo of the SuperCos1 vector with a 5247 bp oriT-attP-int-aac(3)IV
fragment (flanked by SspI recognition sites), which was isolated by
SspI restriction digestion of pMJCOS1[47] (now known as pIJ10702,
Figure S9). Replacement occurred through double-crossover re-
combination at homologous flanking sequences to yield the conju-
gative and integrative pIJ13035, which was then introduced into
the heterologous hosts S. coelicolor M1152 and S. coelicolor M1316
(Table S1) by intergeneric conjugation,[44] whereupon it integrated
into the host’s genome at the chromosomal fC31 attB site to yield
S. coelicolor M1818 and S. coelicolor M1819, respectively. The ex-
conjugants were selected on SFM agar containing apramycin and
nalidixic acid and streaked for a couple of passages on the same
agar to ensure complete removal of the E. coli donor strain. Chro-
mosomal integration of pIJ13035 was confirmed by PCR amplifica-
tion of selected vem genes by using two primer pairs:
SVEN0487TF/SVEN0487TR (flanking vemJ) and SVEN0493TF/
SVEN0493TR (flanking vemA, Table S2). The resulting S. coelicolor
strains were grown until fully sporulated, and the spores were har-
vested and stored at @20 8C in glycerol (20%).[44]
Constitutive expression of vemR : The vemR coding sequence
(from start to stop codon) was amplified from cosmid SV3E02 by
using primers SVEN0492NdeIF1 and SVEN0492HindIIIR (Table S2)
and blunt-end cloned into pBlueScript II KS(+) at the SmaI site. Re-
striction enzyme digestion and DNA sequencing by using M13 uni-
versal primers and designed sequencing primers SVEN0492NW1,
SVEN0492NW2, SVEN0492W3, SVEN0492W4 and SVEN0492NW5
(Table S2) were used to verify the cloned fragment, which was
then inserted downstream of the constitutive ermE* promoter in
pIJ10257 (which integrates at the host’s chromosomal fBT attB
site[33]), creating pIJ13028 in E. coli DH5a (Figure S10).[42] pIJ13028
and pIJ10257 were then introduced by conjugation into S. venezue-
lae wild type, S. venezuelae SV13 (DbldM), S. coelicolor M1818
(M1152::pIJ13035) and S. coelicolor M1819 (M1316::pIJ13035).
pIJ13028 was also introduced into S. coelicolor M1152 and S. coeli-
color M1316 to generate vemR expression control strains. S. coeli-
color ex-conjugants were selected on SFM agar containing hy-
gromycin and nalidixic acid whereas MYM-TAP agar was used for
the S. venezuelae strains. The resulting strains were streaked on the
same media containing hygromycin and nalidixic acid until the
strains were free of E. coli cells. The resulting recombinant strains
were verified by PCR with primers pIJ86F1 and SVEN0492HindIIIR
(Table S2) and grown until fully sporulated, and the spores were
harvested and stored at @20 8C in glycerol (20%).
Constitutive expression of halogenase genes : A PCR fragment
containing the coding sequences of vemJKL and the ribosomal
binding site of vemJ was amplified by using primers SVEN0487-
BamHIF and SVEN0489HindIIR and cloned into pBluescript II KS(+)
cleaved with SmaI. The cloned fragment was verified by restriction
enzyme digestion and DNA sequencing with use of M13 universal
primers and designed sequencing primers SVEN0487W1,
SVEN0488W1, SVEN0488W2 and SVEN0489W1 (Table S2) and insert-
ed downstream of the constitutive ermE* promoter in the multi-
copy pIJ12477 cut with BamHI and HindIII, creating pIJ13029
(ermE*p::vemJKL, Figure S10). pIJ13029 and pIJ12477 (vector-only
control) were then introduced into Streptomyces strains by inter-
generic conjugation as previously described.[44] S. coelicolor ex-con-
jugants were selected on SFM agar containing kanamycin and nali-
dixic acid, whereas MYM-TAP agar containing trace element solu-
tion and kanamycin was used for the S. venezuelae ex-conjugants.
Ex-conjugants were verified by PCR amplification with primer pair
pIJ86F1 and pIJ86R2 (Table S2), which anneal at sites within
pIJ12477 220 and 229 bp from the BamHI and HindIII cloning sites
of the vector, respectively. The resulting strains were grown on
agar, and spores were stored as previously described.
Analysis of culture supernatants : Stationary-phase cultures were
centrifuged at 13000 rpm in a fixed angle rotor refrigerated micro-
centrifuge at 4 8C for 20 min to remove mycelium. Samples were
analysed by using two different systems and sets of conditions:
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A) A Shimadzu LC-MS system equipped with a NexeraX2 liquid chro-
matograph (LC30AD) fitted with a Prominence photodiode array de-
tector (SPD-M20A) and an LC-MS-IT-ToF mass spectrometer : Samples
(typically 5 mL) were injected onto a Kinetex XB C18 (2.6 mm, 100 a,
50 mm by 2.1 mm) column (part no. 00B-4496-AN, Phenomenex,
USA) fitted with a KrudKatcher Ultra HPLC inline filter (part no.
AF0—8497, Phenomenex), kept at 40 8C and eluted at a flow rate
of 0.6 mLmin@1 with a gradient of 0.1% formic acid in water and
methanol, from 2% to 100% methanol over 7 min. Data acquisi-
tion and analysis were performed with LCMS solution version 3
(Shimadzu).
B) A Dionex 3000RS UHPLC coupled to a Bruker MaXis Q-TOF mass
spectrometer with an Agilent Zorbax Eclipse plus column (C18, 100V
2.1 mm, 1.8 mm): Mobile phases consisted of A (water with 0.1%
formic acid) and B (acetonitrile with 0.1% formic acid). A gradient
of 5% B to 100% B in 15 min was employed with a flow rate of
0.2 mLmin@1, with UV absorption set at 254 nm.
Purification of venemycin by semipreparative HPLC and NMR
spectroscopy : Venemycin was purified from the concentrated cul-
ture supernatant by semipreparative HPLC on a reversed-phase
column (C18, 100V21 mm, fitted with a C18 pre-column 10V
21 mm). The mobile phase contained water and acetonitrile, both
with formic acid (0.1%) added. The gradient used was: 0–10 mi-
nutes, 10% acetonitrile; 10–30 minutes, 10% acetonitrile to 100%
acetonitrile; 30–35 minutes, 100% acetonitrile; the column was
then restored to its initial state (10% acetonitrile) for 15 minutes
before reuse. Absorbance was monitored at a wavelength of
324 nm. Fractions containing venemycin were identified by ESI-MS
and combined. The combined fractions were evaporated under re-
duced pressure, freeze-dried, reconstituted into [D6]DMSO (180 mL)
and transferred to a 3 mm NMR tube. 1H, HSQC and HMBC experi-
ments were carried out with a Bruker Avance II 400 MHz NMR
spectrometer.
Assay of antibacterial activity : Colonies of M. luteus ATCC4698
and E. coli ATCC25922 freshly grown on lysogeny broth (LB) agar
plates were used separately to inoculate LB broth (10 mL) followed
by overnight cultivation at 30 8C. Overnight culture (0.2 mL) was
used to inoculate LB (10 mL) and cultivation at 30 8C was contin-
ued until an OD 600 of 0.6–0.8 was reached. The culture (1 mL) was
added to LB-agar medium (50 mL) at about 45 8C, and 25 mL were
poured into 10V10 cm plates. Culture supernatant (100 mL) was
added to wells made in the solidified agar, and plates were incu-
bated at 30 8C for 24–48 h, after which they were monitored for
the appearance of inhibitory halos. Kanamycin (25 mgmL@1) was
used as positive control.
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